Position
Fidelity in Lexeo Therapeutics, Inc.
Back to the book · All holders of LXEO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$26.5K$5.74 → $4.66
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 13.4K | $132.9K | — | — | — | 0.0% |
| Q1 2026 | 24.4K | $140K | $5.74 | −$56.1K | $63.1K | 0.0% |
| Q2 2026 | 141.1K | $657K | $4.66 | −$26.5K | $543.5K | 0.0% |